Natural Alternatives International, Inc. (NASDAQ:NAII) Short Interest Update

Share on StockTwits

Natural Alternatives International, Inc. (NASDAQ:NAII) was the recipient of a large drop in short interest in the month of November. As of November 29th, there was short interest totalling 7,100 shares, a drop of 42.3% from the November 14th total of 12,300 shares. Currently, 0.1% of the company’s stock are sold short. Based on an average trading volume of 12,000 shares, the days-to-cover ratio is presently 0.6 days.

NAII has been the subject of several research reports. ValuEngine upgraded Natural Alternatives International from a “hold” rating to a “buy” rating in a report on Tuesday, December 3rd. TheStreet lowered Natural Alternatives International from a “b-” rating to a “c+” rating in a report on Thursday, September 26th.

Shares of Natural Alternatives International stock traded up $0.15 during trading on Thursday, hitting $8.15. 18,000 shares of the stock traded hands, compared to its average volume of 9,229. The stock has a market cap of $55.40 million, a P/E ratio of 13.80 and a beta of 0.25. The company has a debt-to-equity ratio of 0.26, a quick ratio of 3.23 and a current ratio of 4.89. Natural Alternatives International has a twelve month low of $7.55 and a twelve month high of $14.25. The company has a fifty day moving average price of $8.48 and a two-hundred day moving average price of $10.02.

Natural Alternatives International (NASDAQ:NAII) last announced its quarterly earnings results on Tuesday, September 24th. The company reported ($0.03) earnings per share (EPS) for the quarter. The firm had revenue of $30.26 million for the quarter. Natural Alternatives International had a net margin of 3.11% and a return on equity of 5.34%.

Institutional investors have recently made changes to their positions in the company. James Investment Research Inc. lifted its holdings in shares of Natural Alternatives International by 31.6% during the 3rd quarter. James Investment Research Inc. now owns 8,325 shares of the company’s stock valued at $69,000 after buying an additional 2,000 shares during the last quarter. LSV Asset Management acquired a new stake in shares of Natural Alternatives International during the 2nd quarter valued at about $69,000. Perritt Capital Management Inc. lifted its holdings in shares of Natural Alternatives International by 7.1% during the 2nd quarter. Perritt Capital Management Inc. now owns 17,140 shares of the company’s stock valued at $200,000 after buying an additional 1,140 shares during the last quarter. BlackRock Inc. lifted its holdings in shares of Natural Alternatives International by 7.7% during the 2nd quarter. BlackRock Inc. now owns 17,497 shares of the company’s stock valued at $204,000 after buying an additional 1,247 shares during the last quarter. Finally, Wedbush Securities Inc. lifted its holdings in shares of Natural Alternatives International by 9.5% during the 3rd quarter. Wedbush Securities Inc. now owns 156,171 shares of the company’s stock valued at $1,304,000 after buying an additional 13,492 shares during the last quarter. Institutional investors and hedge funds own 33.04% of the company’s stock.

About Natural Alternatives International

Natural Alternatives International, Inc engages in formulating, manufacturing, and marketing nutritional supplements in the United States and internationally. It operates through two segments, Private-Label Contract Manufacturing, and Patent and Trademark Licensing. The company offers private-label contract manufacturing services to companies that market and distribute vitamins, minerals, herbal, and other nutritional supplements, as well as other health care products.

Recommended Story: Dollar Cost Averaging

Receive News & Ratings for Natural Alternatives International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Natural Alternatives International and related companies with MarketBeat.com's FREE daily email newsletter.

 


Latest News

Yu Darvish Receives Cortisone Shot for Elbow Impingement
Yu Darvish Receives Cortisone Shot for Elbow Impingement
Red Sox and Brandon Phillips Agree to Minor League Deal
Red Sox and Brandon Phillips Agree to Minor League Deal
Chris Sale Proves He is 2018 AL Cy Young Candidate
Chris Sale Proves He is 2018 AL Cy Young Candidate
Strong Results by Clint Frazier Could Keep Him with Yankees
Strong Results by Clint Frazier Could Keep Him with Yankees
Giants Closer Breaks Hand Punching Door Following Poor Outing
Giants Closer Breaks Hand Punching Door Following Poor Outing
Evan Longoria Out Six to Eight Weeks With Broken Hand
Evan Longoria Out Six to Eight Weeks With Broken Hand


 
© 2006-2020 BBNS.